Illumina, Inc. (LON:0J8Z)
London · Delayed Price · Currency is GBP · Price in USD 97.91
+1.94 (2.02%)
At close: Oct 30, 2025
Illumina Market Cap
Illumina has a market cap or net worth of 14.46 billion as of October 31, 2025. Its market cap has decreased by -17.93% in one year.
Market Cap
14.46B
Enterprise Value
15.39B
Revenue
3.20B
Ranking
n/a
PE Ratio
27.59
Stock Price
97.91
Market Cap Chart
Since July 28, 2000, Illumina's market cap has increased from 174.80M to 14.46B, an increase of 8,174.36%. That is a compound annual growth rate of 19.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 14.46B | -14.56% |
| Dec 31, 2024 | 16.93B | -2.48% |
| Dec 29, 2023 | 17.36B | -34.24% |
| Dec 30, 2022 | 26.40B | -39.89% |
| Dec 31, 2021 | 43.92B | 10.99% |
| Dec 31, 2020 | 39.57B | 7.46% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.77B |
| GSK plc | 70.40B |
| Haleon | 30.72B |
| Smith & Nephew | 11.60B |
| ConvaTec Group | 4.82B |
| Hikma Pharmaceuticals | 4.04B |
| HUTCHMED (China) | 1.88B |
| Genus | 1.68B |